Perspectives du marché et avis des analystes :
Le rapport inclut les perspectives de croissance ainsi que les tendances actuelles du marché des dispositifs de neuromodulation et leur impact prévisible au cours de la période de prévision.
L'utilisation de la neuromodulation connaît une croissance rapide, avec un large gamme de méthodes technologiques implantables et non invasives pour le traitement des troubles neuropsychiatriques et neurologiques. Des thérapies telles que la stimulation corticale intracrânienne (ICS), la stimulation magnétique transcrânienne (TMS), la stimulation cérébrale profonde (DBS) et la stimulation transcrânienne à courant continu (tDCS) ont montré des résultats prometteurs dans une gamme de troubles neuropsychiatriques et neurologiques. Les appareils de neuromodulation sont des instruments médicaux avancés capables d’ajuster l’activité du système nerveux. La technologie est utilisée pour traiter les troubles du mouvement tels que la dystonie, la maladie de Parkinson, les tremblements ; acouphène; trouble obsessionnel compulsif; handicaps sensoriels; épilepsie; contrôle de la vessie ; mal de tête; la douleur chronique; accident vasculaire cérébral; état de conscience minimale ; spasticité; et des lésions de la moelle épinière. Des facteurs tels que l'augmentation des cas de lésions de la moelle épinière et la prévalence croissante des troubles neurologiques contribuent à la taille croissante du marché des dispositifs de neuromodulation.
Facteurs du marché :
La population gériatrique est sensible aux maladies neurologiques. Les troubles neurologiques courants affectant les personnes âgées sont la neuropathie, la maladie de Parkinson, la maladie d'Alzheimer, la dystonie et d'autres. Selon le Département des affaires économiques et sociales des Nations Unies, en 2022, il y avait dans le monde 771 millions de personnes âgées de 65 ans et plus. La population âgée devrait atteindre 994 millions d’ici 2030 et 1 600 millions d’ici 2050. Des pays comme les États-Unis et le Canada ont des taux de prévalence élevés de troubles du mouvement et de troubles psychiatriques associés à une population gériatrique croissante. Selon la Fondation Parkinson, les symptômes de la maladie de Parkinson sont fréquents à l'âge moyen de 60 ans.
La Société canadienne de psychologie affirme que le trouble obsessionnel-compulsif (TOC) touche environ 2 % de la population au Canada. L'Organisation mondiale de la santé (OMS) déclare que l'épilepsie est un trouble neurologique provoquant des crises qui touche environ 50 millions de personnes dans le monde. Selon l'Académie américaine de neurologie, l'accident vasculaire cérébral est la troisième cause de décès aux États-Unis, suivi par la maladie d'Alzheimer comme la sixième cause de décès. Les statistiques de la même source montrent que près d'un million d'Américains sont touchés par la maladie de Parkinson et qu'au moins 60 000 nouveaux cas sont signalés chaque année. La prévalence croissante des maladies neurologiques associée à des troubles liés au mode de vie tels que la dépression et la douleur chronique conduit à l'adoption croissante de produits technologiquement avancés.
Par conséquent, la population gériatrique croissante est sujette aux maladies neurologiques, ce qui entraîne une prévalence croissante de ces maladies. et la prise de conscience croissante de l'énorme fardeau des troubles neurologiques stimulent la croissance du marché des dispositifs de neuromodulation.
Les neurosciences se concentrent sur le traitement de troubles tels que les accidents vasculaires cérébraux, les maux de tête, la sclérose en plaques et d'autres cas graves. Ces dernières années, une relative pénurie de main-d’œuvre neurologique qualifiée a été constatée même dans les pays développés. Aux États-Unis, il existe plus de 5 700 hôpitaux ; cependant, ces hôpitaux comptent moins de 3 700 neurochirurgiens. Un facteur important responsable de l'insuffisance du personnel neurochirurgical est l'incapacité de produire des neurochirurgiens correctement formés dans un laps de temps approprié. Des installations de neurologie dotées d’une technologie de pointe sont disponibles dans les zones urbaines. Cependant, des traitements limités sont proposés dans les zones rurales en raison du manque de professionnels experts. Par conséquent, la pénurie de neurochirurgiens qualifiés entrave la croissance du marché des dispositifs de neuromodulation.
Aperçus stratégiques
Segmentation et portée du rapport :
L'analyse du marché des dispositifs de neuromodulation a été réalisée. en considérant les segments : type, application, biomatériau et utilisateur final.
Analyse segmentaire :
Le marché des appareils de neuromodulation, par type, est divisé en externe et interne. Le segment de neuromodulation interne détenait une part de marché des appareils de neuromodulation plus importante en 2022. Cependant, le segment de neuromodulation externe est susceptible d’enregistrer un TCAC plus élevé au cours de la période 2022-2030. Le terme « neuromodulation interne » décrit l'utilisation de dispositifs médicaux qui fournissent des formes de stimulation électrique, chimique ou autre à des cibles neuronales spécifiques afin de moduler ou de modifier l'activité du système nerveux. Cette technique est utilisée pour traiter les maladies neurovasculaires, les anomalies du mouvement, l'épilepsie, la douleur chronique et l'incontinence fécale et urinaire.
Marché des dispositifs de neuromodulation, par type – 2022 et 2030
Par utilisateur final, le Le marché des appareils de neuromodulation est segmenté en hôpitaux, cliniques et soins de santé à domicile. En 2022, le segment des hôpitaux dominait la part de marché des appareils de neuromodulation. En raison de l’expansion de nombreux hôpitaux et cliniques et de l’augmentation des dépenses gouvernementales pour construire des infrastructures de santé, le segment des hôpitaux domine actuellement le marché. De plus, le vieillissement de la population devrait entraîner une prévalence plus élevée de douleur chronique, stimulant ainsi la demande de dispositifs de neuromodulation dans les hôpitaux.
Analyse régionale :
La portée du rapport sur le marché des dispositifs de neuromodulation est principalement segmenté en Amérique du Nord (États-Unis, Canada et Mexique), Europe (Espagne, Royaume-Uni, Allemagne, France, Italie et reste de l'Europe), Asie-Pacifique (Corée du Sud, Chine, Inde, Japon, Australie et le reste de l'Asie-Pacifique), le Moyen-Orient et l'Afrique (Afrique du Sud, Arabie Saoudite, Émirats arabes unis et reste du Moyen-Orient et d'Afrique), et l'Amérique du Sud et centrale (Brésil, Argentine et reste de l'Amérique du Sud et centrale). ).
En termes de revenus, l'Amérique du Nord a dominé la part de marché des appareils de neuromodulation en 2022. La prévalence croissante des maladies neurologiques, les dépenses élevées en recherche et développement, le nombre croissant d'approbations de produits par la FDA et les progrès technologiques. stimuler la demande d'appareils de neuromodulation dans la région.
Paysage concurrentiel et entreprises clés :
Le rapport sur le marché des appareils de neuromodulation se concentre sur des acteurs de premier plan du marché tels qu'Abbott (St. Jude Medical, Inc), LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioventus, EnteroMedics Inc, Nevro Corporation, NeuroPace Inc, Synapse Biomedical Inc et Neurosigma Inc. Les prévisions du marché des dispositifs de neuromodulation peuvent aider les parties prenantes à planifier leurs stratégies de croissance. Ces entreprises se concentrent sur les nouvelles technologies, la mise à niveau des produits existants et l'expansion du marché pour répondre à la demande croissante des consommateurs du monde entier. Selon les communiqués de presse de l'entreprise, vous trouverez ci-dessous quelques développements clés récents :
En août 2023, Medtronic plc a reçu l'approbation du marquage CE pour son stimulateur de moelle épinière (SCS) rechargeable en boucle fermée Inceptiv. Il s'agit du premier appareil Medtronic SCS à offrir une fonction en boucle fermée qui détecte les signaux biologiques uniques de chaque personne et ajuste la stimulation à chaque instant, selon les besoins, pour maintenir la thérapie en harmonie avec les mouvements de la vie quotidienne. En août 2023, Abbott a reçu l'approbation de la Food and Drug Administration (FDA) des États-Unis pour son nouveau système de stimulation de la moelle épinière (SCS) Proclaim Plus doté de la thérapie FlexBurst360. La thérapie FlexBurst360, nouvelle génération de stimulation BurstDR exclusive d'Abbott, offre une couverture de la douleur sur six zones du tronc et/ou des membres. Il facilite une programmation qui peut être ajustée selon les besoins thérapeutiques d'une personne.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Neuromodulation use is growing rapidly, with a wide range of implantable and noninvasive technology-based methods for the treatment of neuropsychiatric and neurological disorders. Therapies such as intracranial cortical stimulation (ICS), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and transcranial direct current stimulation (tDCS) have shown promising results across a range of neuropsychiatric and neurological disorders. Neuromodulation devices are advanced medical instruments that can adjust the activity of the nervous system. The technology is used to treat movement disorders such as dystonia, Parkinson’s disease, and tremor; tinnitus; obsessive compulsive disorder; sensory disabilities; epilepsy; bladder control; headache; chronic pain; stroke; minimally conscious state; spasticity; and spinal cord injury.
The factors that are driving growth of the market are the rising cases of spinal cord injury and increasing prevalence of neurological disorders.
The neuromodulation device market majorly consists of the players such as Abbott (St. Jude Medical, Inc.), LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioventus, EnteroMedics Inc, Nevro Corporation, NeuroPace Inc, Synapse Biomedical Inc, Neurosigma Inc among others.
US holds the largest market share in neuromodulation device market. the incidence of neurovascular diseases is rising significantly, and it is among the leading causes of death across the country. Rising incidence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neuromodulation devices market growth in the US.
The neuromodulation device market, based on type, is bifurcated into external and internal. The internal neuromodulation segment held a larger neuromodulation devices market share in 2022. However, the external neuromodulation segment is likely to register a higher CAGR during 2022–2030.
The neuromodulation device market, based on application, is segmented into deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). The spinal cord stimulation segment held the largest market share in 2022 and is expected to record the highest CAGR in the market during 2022–2030.
The neuromodulation device market, based on application, is segmented into metallic, polymeric, and ceramic. In 2022, the metallic segment dominated the market share. However, the polymeric segment is likely to register the highest CAGR during 2022–2030.
The neuromodulation device market, based on end user, segmented into hospitals, clinics, and home healthcare. In 2022, the hospitals segment dominated the neuromodulation devices market share.
Asia Pacific is expected to be the fastest growing region in the neuromodulation device market. The rising prevalence of neurological diseases and the development of neuromodulation devices are likely to enhance the market's growth in the coming years. China is among the most populated countries in the world, and the country has a maximum number of patients suffering from neurological disorders.
The List of Companies - Neuromodulation Devices Market
- Abbott (St. Jude Medical, Inc.)
- LivaNova PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Bioventus
- EnteroMedics Inc.
- Nevro Corporation
- NeuroPace Inc.
- Synapse Biomedical, Inc.
- Neurosigma, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Feb 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Feb 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)